These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9145182)

  • 1. The use of biologics in the treatment of rheumatoid arthritis (RA)--the good news and the bad news.
    McQueen FM
    Aust N Z J Med; 1997 Apr; 27(2):175-84. PubMed ID: 9145182
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?
    Jorgensen C; Apparailly F; Sany J
    Ann Rheum Dis; 1999 Mar; 58(3):136-41. PubMed ID: 10364909
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytokine pathways and joint inflammation in rheumatoid arthritis.
    Choy EH; Panayi GS
    N Engl J Med; 2001 Mar; 344(12):907-16. PubMed ID: 11259725
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunotherapy in rheumatoid arthritis; current status].
    Breedveld FC; van de Putte LB
    Ned Tijdschr Geneeskd; 1996 Jun; 140(24):1255-9. PubMed ID: 8700279
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prospects of immunotherapy in rheumatoid arthritis].
    Lotz M
    Rev Rhum Ed Fr; 1993 Jan; 60(1):3-9. PubMed ID: 8242024
    [No Abstract]   [Full Text] [Related]  

  • 6. Biological therapies: a novel approach to the treatment of autoimmune disease.
    Fox DA
    Am J Med; 1995 Jul; 99(1):82-8. PubMed ID: 7598148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New therapeutic possibilities. Future aspects].
    Rubbert A; Burmester GR
    Internist (Berl); 1993 Sep; 34(9):841-51. PubMed ID: 8407201
    [No Abstract]   [Full Text] [Related]  

  • 8. The role and therapeutic targeting of IL-6 in rheumatoid arthritis.
    Narazaki M; Tanaka T; Kishimoto T
    Expert Rev Clin Immunol; 2017 Jun; 13(6):535-551. PubMed ID: 28494214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New immunologic treatment of rheumatoid arthritis].
    Sany J
    Rev Rhum Ed Fr; 1993 Mar; 60(3):229-39. PubMed ID: 8293009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New approaches to biological immunomodulation therapy of rheumatoid arthritis: neutralization of basic cytokines].
    Lukina GV; Sigidin IaA; Skurkovich SV; Skurkovich BS
    Ter Arkh; 1998; 70(5):32-7. PubMed ID: 9644739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological treatment of rheumatoid arthritis.
    Sany J
    Clin Exp Rheumatol; 1990; 8 Suppl 5():81-8. PubMed ID: 2245532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Physiopathology and therapy of rheumatoid arthritis].
    Hashimoto H
    Nihon Naika Gakkai Zasshi; 1998 Mar; 87(3):402-6. PubMed ID: 9577565
    [No Abstract]   [Full Text] [Related]  

  • 13. [New strategies in the immunotherapy of autoimmune diseases].
    Lorenz HM; Geiler T
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1023-8. PubMed ID: 11555778
    [No Abstract]   [Full Text] [Related]  

  • 14. [Monoclonal antibodies as an immunotherapy of rheumatoid arthritis].
    Abe T; Takeuchi T
    Nihon Rinsho; 1998 Mar; 56(3):776-81. PubMed ID: 9549372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of biologics in the treatment of rheumatoid arthritis (RA).
    Manolios N
    Aust N Z J Med; 1997 Oct; 27(5):607-8. PubMed ID: 9404603
    [No Abstract]   [Full Text] [Related]  

  • 16. [Paradigm shift in the treatment of rheumatoid arthritis by biologics].
    Tanaka Y
    Rinsho Byori; 2008 Apr; 56(4):309-15. PubMed ID: 18516965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological agents in rheumatoid arthritis.
    Weinblatt ME
    J Rheumatol Suppl; 1992 Jan; 32():85-8; discussion 88-91. PubMed ID: 1613738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Mechanisms and Novel Targets in Rheumatoid Arthritis.
    Venuturupalli S
    Immunol Allergy Clin North Am; 2017 May; 37(2):301-313. PubMed ID: 28366478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, open-label, comparative, 6-month trial of oral ultra-low doses of antibodies to tumor necrosis factor-alpha and diclofenac in rheumatoid arthritis.
    Dugina JL; Petrov VI; Babayeva AR; Martyushev-Poklad AV; Tcherevkova EV; Epstein OI; Sergeeva SA
    Int J Tissue React; 2005; 27(1):15-21. PubMed ID: 15847101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives of ofatumumab as CD20 targeted therapy in rheumatoid arthritis and other autoimmune diseases.
    Pers YM; Jorgensen C
    Immunotherapy; 2016 Sep; 8(9):1091-6. PubMed ID: 27485081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.